Abbey shareholders increasingly isolated
Moneybags
Article Category: Moneybags
Paddy Coveney rolls the dice at Greencore
First Derivatives’ sky-high share rating
Fyffes shareholders betting on a takeover battle
Venn Life Sciences profit prescription
Market cools as INM soap opera turns ugly
Opaque figures make it hard for Origin investors
Bloodstock blues for Goffs
Deadline approaching for ‘The Irish Times’
Carroll and Heraty’s focus unlikely to boost CPL share price
Nama damned by Project Eagle report
Smurfit Kappa shares lag market average
McCann property company has some value
Smurfit dynasty goes out with a whimper
Fyffes strange plunge into mushrooms
Dermot Smurfit’s high stakes gamble with GAN
Profitable Kingspan needs to avoid distractions
Ormonde Mining’s heavy metal fatigue
Cheap Abbey shares stuck in bargain basement
Muldoon’s clean sweep puts FBD on course
Mick Carvill survives Kenmare restructuring
What’s next for Doyle hotels?
Shareholders hit by Aminex dilution
More pain at Providence Resources
Moguls taking on Denis O’Brien
Draper Esprit’s potential comes with health warning
Polymetal stake should boost Ovoca
ICG shareholders set for turbulent waters post Brexit
Market has pushed Datalex shares sky high
No quick cure for Amryt Pharma investors
PTSB launches ‘Explore Account’
Pricey Grafton shares have potential
Aminex shares now good for a gamble
Paddy Power Betfair shares on very high rating
Hostelworld’s success could attract competition
Vultures profit from Nama strategy